Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Breast Cancer Congress 2023

From familial to theranostic germline genetics in breast cancer

Current advances in breast cancer risk assessment: Prime time for a personalised approach?

Date

11 May 2023

Session

From familial to theranostic germline genetics in breast cancer

Topics

Population Risk Factor;  Cancer Intelligence (eHealth, Telehealth Technology, BIG Data);  Primary Prevention;  Secondary Prevention/Screening;  Genetic and Genomic Testing;  Statistics;  Genetic Testing and Counselling

Tumour Site

Breast Cancer

Presenters

Antonis Antoniou

Authors

A. Antoniou

Author affiliations

  • University of Cambridge School of Clinical Medicine, Cambridge/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Presenter: To be Announced

Session: From familial to theranostic germline genetics in breast cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.